Skip Navigation

Faculty Directory

Kala Visvanathan, MBBS

Director of the Cancer Epidemiology Track, Department of Epidemiology, Member of the Cancer Prevention & Control Program, Breast Program, Female Reproductive Cancers Program at SKCCC, Director of the Clinical Cancer Genetics & Prevention Service at SKCCC

Associate Professor

Departmental Affiliation(s):

Epidemiology

Center & Institute Affiliation(s):

Contact Information

E 6142 615 N Wolfe St.
Baltimore , Maryland   21205
US        

410 614 -1112
410 614 2632

Education

MBBS , University of Sydney , 1989
MHS , Johns Hopkins Bloomberg School of Public Health , 1998
FRACP , 1996

Overview

Dr Visvanathan is a cancer epidemiologist and a medical oncologist with an interest in the etiology, early detection and prevention (both primary and secondary) of breast and ovarian cancer in both the general and high-risk populations.

Her research interests include: 1) the evaluation of biomarkers/exposures (i.e. hormones, obesity, inflammation) to identify women at risk for developing breast and ovarian cancer 2) the identification of host factors and exposures associated with primary and secondary breast and ovarian cancer prevention 3) the conduct of early detection and chemoprevetion studies/trials i.e sulforaphane.

 

Honors and Awards

1999 AACR-Glaxo Welcome Oncology Scholar Award for Clinical/Translational Research

2001 First Prize in Clinical section John’s Hopkins Fellow Research Day 2004 -2005

JHU Breast SPORE Career Development Award

2005 ASCO Career Development Award 2005

K07 Preventive Oncology Award

cancer epidemiology,cancer prevention, etiology, early detection, risk assessment, genetics, chemoprevention,  breast and ovarian cancer, biomarkers,

  • Selected Publications

  • Visvanathan K., Santor D., Ali S.Z., Brewster A., Arnold A,. Armstrong D.K., Davidson N.E., and Helzlsouer K.J. The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer – a potential tool for breast cancer risk assessment and biomarker evaluation CEBP 2007, 16(5):950-5

  • Cornblatt BS, Ye L, Dinkova-Kostova AT, Erb M, Fahey JW, Singh NK, Chen MS, Stierer T, Garrett-Meyer E, Argani P, Davidson NE, Talalay P, Kensler TW, Visvanathan K. Preclinical and Clinical Evaluation of Sulforaphane for Chemoprevention in the Breast. Carcinogenesis. 2007,1485-90.

  • Berrington de Gonzalez A, Berg CD, Visvanathan K, Robson M. Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers JNCI 2009,101(3) 205-9.

  • Jorgensen TJ, Helzlsouer KJ, Clipp SC, Bolton JH, Crum RM, Visvanathan K. CEBP 2009;18:346-350.